Novidin (Hydroxychloroquine Sulfate)

Hydroxychloroquine sulfate accumulates in lysosomes, raising their pH and inhibiting enzymes involved in autophagy and antigen presentation. This interferes with Toll‑like receptor signaling, reducing cytokine production and modulating immune responses. In malaria parasites, it disrupts heme polymerization, leading to toxic heme accumulation and parasite death.

The dosage of Novidin is determined by the prescribing healthcare professional based on the specific indication, patient characteristics, and local guidelines. Physicians tailor the dose to achieve optimal therapeutic effect while minimizing risk, and patients should follow the prescriber’s instructions exactly.

Novidin is classified as pregnancy category B, indicating that animal studies have not shown risk but there are limited human data. It may be used during pregnancy only when the potential benefit justifies the potential risk. Breastfeeding is not contraindicated, but the prescriber should evaluate the risk‑benefit ratio for mother and infant.

To order Novidin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and assistance with import documentation.

Novidin (hydroxychloroquine) offers both antimalarial activity and immunomodulatory effects, making it useful for infectious and autoimmune indications. Compared with other antimalarials such as chloroquine, hydroxychloroquine has a better safety profile and longer half‑life. Within the DMARD class, it is generally milder than biologics but effective for early disease control and maintenance therapy.

Novidin should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability throughout its shelf life.

Novidin is taken orally, usually as a tablet swallowed with water. The exact timing (e.g., with food or on an empty stomach) should follow the prescribing clinician’s guidance, and patients should not alter the dosing schedule without medical advice.

The most serious adverse effects of Novidin include retinal toxicity that can lead to permanent vision loss, cardiac arrhythmias such as QT prolongation, and hemolytic anemia in individuals with glucose‑6‑phosphate dehydrogenase (G6PD) deficiency. Regular monitoring and prompt reporting of visual changes or cardiac symptoms are essential.

Novidin is contraindicated in patients with known hypersensitivity to hydroxychloroquine or related compounds, in individuals with pre‑existing retinal disease, and in those with G6PD deficiency due to the risk of hemolysis. Caution is also advised for patients with severe cardiac conditions or uncontrolled diabetes.